v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues
Operating expenses:    
General and administrative 262,149 341,203
Research and development 117,064 13,214
Stock-based compensation 210,016 231,933
Total operating expenses 589,229 586,350
Interest expense, net 1,260 909
Net loss $ (590,489) $ (587,259)
Net loss per share - basic $ (0.03) $ (0.03)
Net loss per share - diluted $ (0.03) $ (0.03)
Weighted average number of common shares outstanding during the period- basic 18,754,739 18,522,295
Weighted average number of common shares outstanding during the period- diluted 18,754,739 18,522,295